PPP6C, a serine-threonine phosphatase, regulates melanocyte differentiation and contributes to melanoma tumorigenesis through modulation of MITF activity

7Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

It is critical to understand the molecular mechanisms governing the regulation of MITF, a lineage specific transcription factor in melanocytes and an oncogene in melanoma. We identified PPP6C, a serine/threonine phosphatase, as a key regulator of MITF in melanoma. PPP6C is the only recurrently mutated serine/threonine phosphatase across all human cancers identified in sequencing studies and the recurrent R264C mutation occurs exclusively in melanoma. Using a zebrafish developmental model system, we demonstrate that PPP6C expression disrupts melanocyte differentiation. Melanocyte disruption was rescued by engineering phosphomimetic mutations at serine residues on MITF. We developed an in vivo MITF promoter assay in zebrafish and studied the effects of PPP6C(R264C) on regulating MITF promoter activity. Expression of PPP6C(R264C) cooperated with oncogenic NRAS(Q61K) to accelerate melanoma initiation in zebrafish, consistent with a gain of function alteration. Using a human melanoma cell line, we examined the requirement for PPP6C in proliferation and MITF expression. We show that genetic inactivation of PPP6C increases MITF and target gene expression, decreases sensitivity to BRAF inhibition, and increases phosphorylated MITF in a BRAF(V600E) mutant melanoma cell line. Our data suggests that PPP6C may be a relevant drug target in melanoma and proposes a mechanism for its action.

References Powered by Scopus

Cancer statistics, 2015

12202Citations
N/AReaders
Get full text

Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal

11197Citations
N/AReaders
Get full text

An integrated stress response regulates amino acid metabolism and resistance to oxidative stress

2685Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Innate immune checkpoint inhibitor resistance is associated with melanoma sub-types exhibiting invasive and de-differentiated gene expression signatures

12Citations
N/AReaders
Get full text

M6A-induced transcription factor IRF5 contributes to the progression of cervical cancer by upregulating PPP6C

3Citations
N/AReaders
Get full text

Melanoma genomics – will we go beyond BRAF in clinics?

2Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Maskin, C. R., Raman, R., & Houvras, Y. (2022). PPP6C, a serine-threonine phosphatase, regulates melanocyte differentiation and contributes to melanoma tumorigenesis through modulation of MITF activity. Scientific Reports, 12(1). https://doi.org/10.1038/s41598-022-08936-0

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 3

60%

Professor / Associate Prof. 1

20%

Researcher 1

20%

Readers' Discipline

Tooltip

Biochemistry, Genetics and Molecular Bi... 3

50%

Computer Science 1

17%

Nursing and Health Professions 1

17%

Arts and Humanities 1

17%

Article Metrics

Tooltip
Social Media
Shares, Likes & Comments: 30

Save time finding and organizing research with Mendeley

Sign up for free